long intergenic non-protein coding RNA 2080Genealiases: []
Q-omics provides the consensus-scored LINC02080 profile across patient tissues and cancer cell-line models. LINC02080 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC02080 is differentially expressed in 10, with the highest sampling consensus in THCA. Additionally, LINC02080 RNA expression shows 13,208 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, THCA, and THYM as cancer lineages where LINC02080 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02080 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02080 survival associations across molecular data types. LINC02080 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02080 RNA expression–survival associations across cancer types. High LINC02080 expression shows unfavorable associations in KIRC, COAD, KIRP and MESO, but favorable associations in ESCA and HNSC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC02080 RNA expression.
This table summarizes LINC02080 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02080. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02080 shows higher tumor expression in THCA, HNSC, BRCA, CHOL, KIRC and ESCA. The THCA box plot shows higher LINC02080 RNA expression in tumor versus normal tissue (log2 FC = +0.061, t-test p = .006).
This table shows molecular features associated with LINC02080 in patient tissues and cancer cell lines. In patient samples, LINC02080 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
